Order Article Reprints

Yendo TM, Sato MN, Branco ACCC, Pietrobon AJ, Teixeira FME, Ramos YÁL, Alberca RW, Valêncio CG, Arruda VN, Romiti R, et al. Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. Vaccines. 2021; 9(5):478. https://doi.org/10.3390/vaccines9050478

Yendo, Tatiana Mina, Maria Notomi Sato, Anna Cláudia Calvielli Castelo Branco, Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Yasmim Álefe Leuzzi Ramos, Ricardo Wesley Alberca, Cesar Giudice Valêncio, Vivian Nunes Arruda, Ricardo Romiti, and et al. 2021. "Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19" Vaccines 9, no. 5: 478. https://doi.org/10.3390/vaccines9050478

Yendo, T. M., Sato, M. N., Branco, A. C. C. C., Pietrobon, A. J., Teixeira, F. M. E., Ramos, Y. Á. L., Alberca, R. W., Valêncio, C. G., Arruda, V. N., Romiti, R., Arnone, M., Hirayama, A. L. d. S., Duarte, A. J. d. S., Aoki, V., & Orfali, R. L. (2021). Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. Vaccines, 9(5), 478. https://doi.org/10.3390/vaccines9050478